Takeda aims for dengue vaccine inclusion in India's shots program

Jab recently approved for disease that infected 120,000 people last year

Takeda Pharmaceutical's Qdenga is the first vaccine to ever be approved for dengue prevention by India's Central Drugs Standard Control Organisation. © Reuters

MUMBAI -- Japanese drugmaker Takeda Pharmaceutical is aiming to have its dengue vaccine become a part of India's national immunization program, a senior company executive said, after the country's regulators approved the product last month.

Bold News stores the normalized extraction for evidence and analysis. This public wrapper shows a limited excerpt; use the original link for the publisher's complete presentation.